VL
Patients with acute VL as well as VL patients receiving sodium stibogluconate treatment displayed significantly increased levels of PEG precipitate-induced GM-CSF.
Patients with acute <span class="disease" id="17404324-8-20-22">VL</span> as well as VL patients receiving sodium stibogluconate treatment displayed significantly increased levels of PEG precipitate-induced <span class="gene" id="17404324-8-156-162">GM-CSF</span>.